Obigen Pharma Inc. (TPEX: 7876)
Health Care · Biotechnology · TW
NT$78.20
+21.81% today · +81.0% 1Y
Obigen Pharma Inc. (TPEX: 7876) operates in the Biotechnology industry within the Health Care sector. The company is valued at $262.25M.
Over the last twelve months the share price has gained 81.0%, trading between 33.75 and 95.70.
Tweenvest scores Obigen Pharma Inc. across four factors: quality 69/100, value 72/100. Its strongest factor is value.
7876 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $262.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.88
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$95.70
- 52-week low
- NT$33.75
- Avg volume (3M)
- —
- Shares outstanding
- 107.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc.NasdaqGM: BBOT | $265.38M | $3.31 | -14.91% |
| Lexeo Therapeutics, Inc.NasdaqGM: LXEO | $265.00M | $3.23 | -8.50% |
| Inventage Lab, Inc.KOSDAQ: A389470 | $263.31M | ₩26,600.00 | -6.01% |
| Santhera Pharmaceuticals Holding AGSWX: SANN | $263.01M | CHF14.28 | -5.56% |
| Anika Therapeutics, Inc.NasdaqGS: ANIK | $262.04M | $19.58 | +1.82% |
| Fate Therapeutics, Inc.NasdaqGM: FATE | $261.21M | $2.18 | -6.03% |
| VISEN PharmaceuticalsSEHK: 2561 | $259.19M | HK$18.61 | +0.59% |
| Healios K.K.TSE: 4593 | $258.52M | ¥302.00 | +5.23% |
Figures last refreshed Oct 11, 2026.